Intraperitoneal LSTA1 in CRS-HIPEC

NCT06216561 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped closed early due to low (0) accrual

Conditions

Colorectal Cancer
Ovarian Carcinoma
Appendix Cancer
Peritoneal Metastases

Interventions

DRUG: CRS-HIPEC + LSTA1
PROCEDURE: CRS-HIPEC alone

Sponsor

University of California, San Diego